Hospital Acquired Methicillin-Resistant Staphylococcus

Document technical information

Format pdf
Size 255.7 kB
First found May 15, 2016

Document content analysis

Category Also themed
Language
English
Type
not defined
Concepts
no text concepts found

Transcript

Hospital Acquired Methicillin-Resistant Staphylococcus
aureus (HA-MRSA) Infections Market Share, Size, Syndrome,
Treatment, Symptoms, Analysis, Pipeline Review, H2 2015
Global Markets Direct's, 'Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA)
Infections - Pipeline Review, H2 2015', provides an overview of the Hospital Acquired MethicillinResistant Staphylococcus aureus (HA-MRSA) Infections's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Hospital Acquired
Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections, complete with comparative analysis
at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along with latest updates, and featured news and press
releases. It also reviews key players involved in the therapeutic development for Hospital Acquired
Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections and special features on late-stage and
discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/hospital-acquiredmethicillin-resistant-staphylococcus-aureus-ha-mrsa-infections-pipeline-review-h2-2015
Scope
The report provides a snapshot of the global therapeutic landscape of Hospital Acquired MethicillinResistant Staphylococcus aureus (HA-MRSA) Infections
The report reviews key pipeline products under drug profile section which includes, product description,
MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Hospital Acquired
Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections and enlists all their major and minor
projects
Table Of Content
Table of Contents 2
List of Tables 4
Browse Upcoming Reports @ http://www.radiantinsights.com/upcoming-reports
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Overview 7
Therapeutics Development 8
Pipeline Products for Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA)
Infections - Overview 8
Pipeline Products for Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA)
Infections - Comparative Analysis 9
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Therapeutics
under Development by Companies 10
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Therapeutics
under Investigation by Universities/Institutes 11
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Products
Glance 12
Clinical Stage Products 12
Early Stage Products 13
Browse Full Report @ http://www.radiantinsights.com/research/hospital-acquired-methicillin-resistantstaphylococcus-aureus-ha-mrsa-infections-pipeline-review-h2-2015
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and individuals procure market research
reports, helping them in the decision making process. We have a comprehensive collection of reports,
covering over 40 key industries and a host of micro markets. In addition to over extensive database of
reports, our experienced research coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: [email protected]
×

Report this document